Article
Primary cutaneous ALCL with phosphorylated/activated cytoplasmic ALK and novel phenotype: EMA/MUC1+, cutaneous lymphocyte antigen negative.
The American journal of surgical pathology - 1 Sept 2008
Kadin Marshall E, Pinkus Jack L, Pinkus Geraldine S, Duran Ivan H, Fuller Christine E, Onciu Mihaela, Kawaguchi Hiroyuki, Morris Stephan W
Abstract excerpt
Primary cutaneous anaplastic large-cell lymphoma (ALCL) ordinarily is distinguished from systemic ALCL by clinical presentation, absence of anaplastic lymphoma kinase (ALK) expression, and immunophenotype (CLA+, EMA/MUC1-). We present an exceptional case of an elderly man with primary cutaneous ALCL and no systemic disease for a 13-year period. Recurrent skin tumors in this patient were characterized by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
